Colon Cancer Screening: The test could increase the number of patients who receive screening for colorectal cancer. The Food and Drug Administration (FDA) has approved a new colorectal cancer (CRC ...

The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your colon ...

According to a news release from Guardant, however, Shield "is the first blood test to be approved by the FDA as a primary screening option for colorectal cancer, meaning healthcare providers can ...

The FDA's approval of Shield (Guardant Health) marks a notable achievement, as individuals at average risk now have the option to receive a simple blood test for CRC screening, starting at age 45.

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but ...

The sensitivity of this blood-based test for colorectal cancer was 83.1%, whereas reported sensitivity of other noninvasive screening tests ranges from 67.3% (95% CI, 57.1 to 76.5) with FIT 15 and ...

The test could serve as an alternative for in-person “Pap smears." The Food and Drug Administration has approved the first at-home screening test for cervical cancer, the product’s maker ...

(CNN) — The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.

A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood ...